Will Japan Embrace Plan B Pill? Sosei Submits NDA For First Emergency Contraceptive Pill
This article was originally published in PharmAsia News
Executive Summary
Tokyo-based biopharmaceutical firm Sosei submitted an NDA for Norlevo (levonorgestrel), Japan's first emergency contraceptive pill. The filing puts Japan one step further to joining a list of 60 countries that have approved the so called "Plan B" or "morning-after pill.
You may also be interested in...
Aska Pharmaceutical Signs License With Sosei On Emergency Contraception Drug
Aska Pharmaceutical signed a license agreement with Sosei Oct. 21 and obtained exclusive rights to market SOH-075, an emergency contraception pill Sosei in-licensed from French Laboratoire HRA Pharma. SOH-075 completed Phase III trials in Japan and an approval is expected by the early half of 2009. According to the agreement, Sosei will receive a ¥300 million upfront payment, as well as potential milestone and royalty payments. Sosei will apply for the new drug approval and Aska will market the drug and conduct post-market surveillance. (Click here for more - Japanese language
PharmAsia News Business Bulletin
A regular roundup of commercial stories appearing in Scrip’s sister publication PharmAsia News, whose multilingual team of regional experts provides authoritative business intelligence focused on the Asian marketplace. Full stories can be accessed by clicking on the story title (subscription required).
PharmAsia News Business Bulletin
A regular roundup of commercial stories appearing in Scrip’s sister publication PharmAsia News, whose multilingual team of regional experts provides authoritative business intelligence focused on the Asian marketplace. Full stories can be accessed by clicking on the story title (subscription required).